Progyny reported a strong fourth quarter with revenue exceeding $100 million for the first time. The company successfully managed the impacts of the COVID-19 pandemic, achieving record levels of revenue, profitability, and operating cash flow.
Revenue was $100.3 million, a 54% increase compared to Q4 2019.
Net income was $39.1 million, or $0.39 income per diluted share.
Adjusted EBITDA was $11.9 million, an increase of $8.0 million from Q4 2019.
The company had 135 clients as of December 31, 2020, compared to 87 clients as of December 31, 2019.
The company is providing financial guidance for the year ended December 31, 2021, and the three-month period ending March 31, 2021.
Visualization of income flow from segment revenue to net income